
Home » CEPHALON UP; GETS FDA APPROVABLE LETTER ON PAIN MED
CEPHALON UP; GETS FDA APPROVABLE LETTER ON PAIN MED
Cephalon Inc. (CEPH) shares jumped 10% Friday after the drug company said the government wanted more information before approving Cephalon's proposed new treatment for cancer pain. Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=984403&contentType=sentryarticle&channelID=29)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
08Feb
-
09Feb
-
15Feb
-
16Feb
-
22Feb
-
07Mar